SEC Form SC TO-I filed by High Income Securities Fund

As filed with the U.S. Securities and Exchange Commission on November 8, 2024

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

SCHEDULE TO

Tender Offer Statement under Section 14(d)(1) or 13(e)(1)

of the Securities Exchange Act of 1934

HIGH INCOME SECURITIES FUND

(Name of Subject Company (Issuer) and Filing Person (Offeror))

  

Common Shares of Beneficial Interest, Without Par Value

(Title of Class of Securities)

 

42968F108

(CUSIP Number of Class of Securities)

 

Phillip Goldstein

Chairman

High Income Securities Fund

615 East Michigan Street

Milwaukee, Wisconsin 53202

(888) 898-4107

(Name, address, and telephone number of person authorized to receive notices and communications on behalf of filing persons)

Copies to:

Thomas R. Westle

Blank Rome LLP

1271 Avenue of the Americas

New York, New York 10020
(212) 885-5239

 

Check the appropriate boxes below to designate any transactions to which the statement relates:

 

 

 

 

 

Check the following box if the filing is a final amendment reporting the results of the tender offer. □

 

If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:

 

 

Introductory Statement

 

This Issuer Tender Offer Statement on Schedule TO relates to an offer by High Income Securities Fund (the “Fund”), a Massachusetts business trust, to purchase for cash up to 10,675,000 of the Fund’s outstanding common shares of beneficial interest, without par value (the “Shares”), upon the terms and subject to the conditions contained in the Offer to Purchase dated November 8, 2024, and the related Letter of Transmittal, which are filed as exhibits to this Issuer Tender Offer Statement on Schedule TO. In accordance with the rules of the U.S. Securities and Exchange Commission (the “Commission”), the Fund may purchase additional shares not to exceed 2% of the outstanding shares (approximately 587,829 shares) without amending or extending the offer.

 

This Issuer Tender Offer Statement on Schedule TO is being filed in satisfaction of the reporting requirements of Rule 13e-4(c)(2) promulgated under the Securities Exchange Act of 1934, as amended.

 

The information in the Offer to Purchase and the related Letter of Transmittal is incorporated herein by reference in answer to Items 1 through 11 of this Issuer Tender Offer Statement on Schedule TO.

Item 12. Exhibits.

 

* Filed herewith.

 

Item 13. Information Required by Schedule 13e-3.

 

Not applicable.

SIGNATURE

 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

Dated:  November 8, 2024

EXHIBIT INDEX

 

---